Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9954593 | 1.00 | KMT2A (0.52) | KMT2AALDH1A1TSHRTHRB | |
| SCHEMBL9954026 | 1.00 | KMT2A (0.52) | KMT2AALDH1A1TSHRTHRB | |
| SCHEMBL526278 | 0.97 | — | — | |
| SCHEMBL9304758 | 0.84 | — | — | |
| SCHEMBL10494077 | 0.80 | TSHR (0.50) | KMT2AALDH1A1TSHRTHRB | |
| SCHEMBL9304699 | 0.80 | TSHR (0.50) | KMT2AALDH1A1TSHRTHRB | |
| SCHEMBL2968811 | 0.76 | — | — | |
| SCHEMBL5839297 | 0.76 | ALDH1A1 (0.56) | KMT2AALDH1A1TSHRTHRB | |
| SCHEMBL989839 | 0.76 | ALDH1A1 (0.56) | KMT2AALDH1A1TSHRTHRB | |
| SCHEMBL9639226 | 0.76 | ALDH1A1 (0.56) | KMT2AALDH1A1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2849794-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE AND USE OF NMR ANALYSES OF THE SAME | Baxter International Inc (US) | 2015-03-25 | — | — | EP | claimed |
| EP-2849795-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | Baxter International Inc (US) | 2015-03-25 | — | — | EP | claimed |
| WO-2013173557-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE AND USE OF NMR ANALYSES OF THE SAME | BAXTER INTERNATIONAL INC. (US) | 2013-11-21 | — | — | WO | claimed |
| WO-2013173543-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | BAXTER INTERNATIONAL INC. (US) | 2013-11-21 | — | — | WO | claimed |
| EP-2598172-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | Baxter International Inc (US) | 2013-06-05 | — | — | EP | claimed |
| EP-2459224-A2 | BLOOD COAGULATION PROTEIN CONJUGATES | Baxter International Inc (US) | 2012-06-06 | — | — | EP | claimed |
| WO-2012016131-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | BAXTER INTERNATIONAL INC. (US) | 2012-02-02 | — | — | WO | claimed |
| WO-2011017055-A2 | BLOOD COAGULATION PROTEIN CONJUGATES | BAXTER INTERNATIONAL INC. (US) | 2011-02-10 | — | — | WO | claimed |
| EP-2849794-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE AND USE OF NMR ANALYSES OF THE SAME | Baxter International Inc (US) | 2015-03-25 | — | — | EP | disclosed |
| EP-2849795-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | Baxter International Inc (US) | 2015-03-25 | — | — | EP | disclosed |
| WO-2013173557-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE AND USE OF NMR ANALYSES OF THE SAME | BAXTER INTERNATIONAL INC. (US) | 2013-11-21 | — | — | WO | disclosed |
| WO-2013173543-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | BAXTER INTERNATIONAL INC. (US) | 2013-11-21 | — | — | WO | disclosed |
| EP-2598172-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | Baxter International Inc (US) | 2013-06-05 | — | — | EP | disclosed |
| WO-2012166622-A1 | THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME | BAXTER INTERNATIONAL INC. (US) | 2012-12-06 | — | — | WO | disclosed |
| EP-2459224-A2 | BLOOD COAGULATION PROTEIN CONJUGATES | Baxter International Inc (US) | 2012-06-06 | — | — | EP | disclosed |
| EP-2459226-A2 | GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS | Lipoxen Technologies Limited (GB) | 2012-06-06 | — | — | EP | disclosed |
| WO-2012016131-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | BAXTER INTERNATIONAL INC. (US) | 2012-02-02 | — | — | WO | disclosed |
| WO-2011012850-A9 | GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2011-05-12 | — | — | WO | disclosed |
| WO-2011017055-A2 | BLOOD COAGULATION PROTEIN CONJUGATES | BAXTER INTERNATIONAL INC. (US) | 2011-02-10 | — | — | WO | disclosed |
| WO-2011012850-A2 | GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2011-02-03 | — | — | WO | disclosed |